TRACON Pharmaceuticals, Inc.
4350 La Jolla Village Drive, Suite 800
San Diego, California 92122
March 24, 2022
Via EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
RE: | TRACON Pharmaceuticals, Inc. |
Registration Statement on Form S-3
File No. 333-263590
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:30 p.m. Eastern Time on March 28, 2022, or as soon thereafter as is practicable.
Thank you for your assistance. If you should have any questions, please contact Matthew Browne of Cooley LLP, counsel to the Registrant, at (858) 550-6045.
TRACON Pharmaceuticals, inc.
By: /s/ Scott Brown
Scott Brown
Chief Financial Officer
